[HTML][HTML] Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study

…, D Karateev, D Andersone, S Rexhepi, Y Yazici… - Arthritis research & …, 2009 - Springer
Introduction Gender as a predictor of outcomes of rheumatoid arthritis (RA) has evoked
considerable interest over the decades. Historically, there is no consensus whether RA is worse …

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid …

…, A Unalp‐Arida, V Vilela, Y Yazici… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To determine the efficacy of a daily dose of 81 mg aspirin in primary thrombosis
prevention in asymptomatic, persistently antiphospholipid antibody (aPL)–positive individuals (…

Behçet syndrome: a contemporary view

H Yazici, E Seyahi, G Hatemi, Y Yazici - Nature Reviews Rheumatology, 2018 - nature.com
The presence of symptom clusters, regional differences in disease expression and similarities
with, for example, Crohn's disease suggest multiple pathological pathways are involved in …

Physical inactivity in patients with rheumatoid arthritis: data from twenty‐one countries in a cross‐sectional, international study

…, C Sheehy, E Quirke, S Celik, Y Yazici… - Arthritis Care & …, 2008 - Wiley Online Library
Objective Regular physical activity is associated with decreased morbidity and mortality.
Traditionally, patients with rheumatoid arthritis (RA) have been advised to limit physical exercise…

RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared …

…, CJ Swearingen, M Bergman, Y Yazici - The Journal of …, 2008 - jrheum.org
Objective To compare 4 categories (high, moderate, and low severity, and near-remission) of
RAPID3 (Routine Assessment of Patient Index Data 3), an index without formal joint counts, …

[HTML][HTML] Apremilast for Behçet's syndrome—a phase 2, placebo-controlled study

…, L Pineda, RM Stevens, H Yazici, Y Yazici - … England Journal of …, 2015 - Mass Medical Soc
… Hasan Yazici, MD, and Yusuf Yazici, MD …

Behçet's syndrome

Y Yazici, I Simsek, H Yazici - Inflammatory Diseases of Blood …, 2012 - Wiley Online Library
Behçet's syndrome is a systemic vasculitis of unknown etiology involving the small and large
vessels of both the venous and arterial systems. Distinct clusters of disease expression …

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs …

Y Yazici, JR Curtis, A Ince, H Baraf… - Annals of the …, 2012 - ard.bmj.com
Objective To evaluate efficacy of tocilizumab in US patients with moderate to severe active
rheumatoid arthritis (RA) and inadequate clinical response to disease-modifying …

Prospects for disease modification in osteoarthritis

SB Abramson, M Attur, Y Yazici - Nature Clinical Practice …, 2006 - nature.com
Osteoarthritis (OA) can be a progressive, disabling disease, leading to diminished quality of
life, and, for over 500,000 individuals annually in the US, total joint replacement. The …

Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities

Y Yazici, T Sokka, H Kautiainen… - Annals of the …, 2005 - ard.bmj.com
Objective: To analyse patients with rheumatoid arthritis, treated with methotrexate in a weekly
academic rheumatology clinic over 13 years, for continuation of courses and reasons for …